Digitoxin medication and cancer; case control and internal dose-response studies
-
* Corresponding author: Johan Haux jhaux@operamail.com
BMC Cancer 2001, 1:11 doi:10.1186/1471-2407-1-11
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 01 May 2001 | |
| Reviewer's Report | Richard Havlik | 07 Jun 2001 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 04 Jul 2001 |
| Resubmission - Version 3 | Manuscript | Author's comment | 04 Jul 2001 |
| Resubmission - Version 4 | Manuscript | 09 Aug 2001 | |
| Resubmission - Version 5 | Manuscript | 10 Aug 2001 | |
| Published | 10 Aug 2001 |